Quick Answer: Clinical evidence shows that the body does not develop true tolerance to tirzepatide's primary glucose-lowering and weight management effects with long-term use
STEP 1: the foundational study This trial enrolled 1,961 adults with BMI of 30 or higher (or 27 with comorbidities) and randomized them to semaglutide 2.4 mg weekly or placebo for 68 weeks
This variability is manageable with proper technique, but it means sublingual dosing requires more attention to administration details than injection ever does
Currently, insurance companies are reluctant to provide coverage for weight-loss drugs, and Medicare, by law, is barred from covering them
The SMGT-GLP-1 Nano Microneedle Slim & Firm Patch offers a long-lasting, slow release of the active ingredients, ensuring a stable effect over 24 hours without causing any discomfort